Around 42% of Medicare Advantage plans offering prescription drug coverage in 2024 will get four or more stars, down from 51% this year and 68% in 2022, according to CMS data. The decline comes amid changes in contract performance scores and the implementation of a new deletion method for performance outliers. The star ratings benefit insurers by determining bonuses and influencing bids against higher benchmark rates.
![](https://healsecurity.com/wp-content/uploads/2024/09/cdc-issues-warning-over-recalled-eggs-sold-in-three-states.jpg)
CDC issues warning over recalled eggs sold in three states
The Centers for Disease Control and Prevention (CDC) has issued a warning against recalled eggs linked to 24 hospitalizations due to salmonella infection. The eggs,